ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.140
-0.050 (-2.28%)
Nov 24, 2025, 4:00 PM EST - Market closed
ProKidney Market Cap
ProKidney has a market cap or net worth of $643.79 million as of November 25, 2025. Its market cap has increased by 179.09% in one year.
Market Cap
643.79M
Enterprise Value
376.30M
1-Year Change
179.09%
Ranking
Category
Stock Price
$2.14
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $50.55M to $643.79M, an increase of 1,173.56%. That is a compound annual growth rate of 78.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 309.98M | 43.33% |
| Dec 31, 2024 | 216.27M | 80.97% |
| Dec 29, 2023 | 119.50M | -71.69% |
| Dec 30, 2022 | 422.17M | 33.72% |
| Dec 31, 2021 | 315.71M | 524.55% |
| Jun 30, 2021 | 50.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |